サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：小児緩和ケア薬市場：薬剤クラス別、投与経路別、流通チャネル別、地域別：規模、シェア、展望、機会分析、2023-2030年
市場調査レポート
商品コード
1350265

小児緩和ケア薬市場：薬剤クラス別、投与経路別、流通チャネル別、地域別：規模、シェア、展望、機会分析、2023-2030年

Pediatric Palliative Care Drugs Market, By Drug Class, By Route of Administration, By Distribution Channel, By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023-2030
出版日: | 発行: Coherent Market Insights | ページ情報: 英文 160 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
小児緩和ケア薬市場：薬剤クラス別、投与経路別、流通チャネル別、地域別：規模、シェア、展望、機会分析、2023-2030年
出版日: 2023年08月24日
発行: Coherent Market Insights
ページ情報: 英文 160 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の小児緩和ケア薬市場は2023年に831億米ドルと推定され、予測期間（2023-2030年）のCAGRは5.1%と予測されます。

レポート対象範囲 レポート詳細
基準年 2022 2023年の市場規模 831億米ドル
過去データ 2018年から2021年 予測期間 2023-2030
予測期間2023年～2030年 CAGR： 5.10% 2030年の価値予測 1,178億米ドル
Pediatric Palliative Care Drugs Market-IMG1

小児緩和ケアは、重篤な疾患を抱える小児に対する専門的な医療ケアです。緩和ケアは、病気の症状やストレスから解放されることに重点を置く。その目的は、子どもと家族のQOL（生活の質）を向上させることです。小児緩和ケアは、どの年齢、どの病期においても適切です。新生児、周産期、乳児、小児、青年、若年成人に適しており、治療と並行して行うことができます。小児緩和ケアは、遺伝性疾患、がん、未熟児、神経疾患、心疾患、肺疾患などの重篤な病状に対応します。痛み、息切れ、疲労、便秘、吐き気、食欲不振、睡眠困難、不安、抑うつなど、これらの病気の症状を緩和します。つまり、子どもと家族の生活の質を向上させる手助けをするのです。小児緩和ケアは、生命を脅かす疾患を持つ子どもとその家族の生活の質を向上させようとする、学際的な協力体制です。世界保健機関（WHO）は、小児緩和ケアを、子どもの身体、心、精神の積極的なトータルケアと定義しており、家族へのサポートも含まれます。緩和ケアで最もよく使われる薬剤は、パラセタモール、イブプロフェン、モルヒネ、ビサコジル、メトロニダゾール、ドンペリドン、デキサメタゾン、ジアゼパムなどです。また、腎不全、筋萎縮性側索硬化症（ALS）、がん、パーキンソン病、慢性閉塞性肺疾患（COPD）、うっ血性心不全（CHF）などの慢性疾患のような重篤な疾患の治療にも使用されます。

市場力学

主要な市場参入企業による新製品の発売や合併・買収の増加が、世界の小児緩和ケア薬市場の成長を促進すると予想されます。例えば、2022年4月1日、日本の製薬会社であるエーザイ株式会社は、デジタルソリューション事業の基盤を強化し、急速に拡大するために、日本のヘルスケアブロックチェーンのスタートアップ企業であるArteryex Inc.の買収を発表しました。両社は、患者、医療従事者、社会全体に向けて、パーソナルヘルスレコード（PHR）関連サービスの開発・提供を共同で行っていく。

本調査の主な特徴

  • 本レポートでは、世界の小児緩和ケア薬市場を詳細に分析し、2022年を基準年とした予測期間（2023～2030年）の市場規模および年間平均成長率（CAGR）を掲載しています。
  • また、さまざまなセグメントにわたる潜在的な収益成長機会を明らかにし、この市場に対する魅力的な投資提案のマトリックスについて解説しています。
  • また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競合戦略などに関する重要な考察も提供しています。
  • 世界の小児緩和ケア薬市場における主要企業を、企業ハイライト、製品ポートフォリオ、主要ハイライト、業績、戦略などのパラメータに基づいてプロファイルしています。
  • 本調査の対象となる主要企業には、Novartis International AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Anqiu Lu'an Pharmaceutical Co., Ltd., Granules India Limited, Zhejiang Kangle Pharmaceutical Co., Ltd., Farmson Pharmaceutical Gujarat Pvt. Ltd., Atabay Pharmaceutical Factory, Anhui Fubore Pharmaceutical & Chemical Co.,Ltd, Huzhou Konch Pharmaceutical Co., Ltd., Alnylam Pharmaceuticals Inc., Eton Pharmaceuticals, Inc, and Eisai Inc.が含まれます。
  • 本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品上市、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
  • この調査レポートは、投資家、サプライヤー、製品メーカー、販売業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者を対象としています。
  • 利害関係者は、世界の小児緩和ケア薬市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場概況

  • レポート概要
    • 市場の定義と範囲
  • エグゼクティブサマリー
  • Coherent Opportunity Map（COM）

第3章 市場力学、規制、動向分析

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 影響分析
  • 最近の製品上市
  • 疫学
  • 合併、買収、提携
  • 規制シナリオ
  • 主な発展
  • PEST分析

第4章 小児緩和ケア薬の世界市場：COVID-19の影響分析

  • 経済的影響
  • COVID-19の疫学
  • 需要と供給への影響

第5章 小児緩和ケア薬の世界市場：薬剤クラス別、2018-2030年

  • 鎮痛薬
  • 制吐剤
  • 緩下剤
  • 補助薬
  • ステロイド
  • 鎮静剤
  • 神経遮断薬
  • その他

第6章 小児緩和ケア薬の世界市場：投与経路別、2018～2030年

  • 経口剤
  • 局所
  • 非経口

第7章 小児緩和ケア薬の世界市場：流通チャネル別、2018年～2030年

  • 病院薬局
  • 小売薬局
  • オンライン薬局

第8章 小児緩和ケア薬の世界市場：地域別、2018年～2030年

  • 北米
  • 米国
  • カナダ
  • ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
  • その他ラテンアメリカ
  • 欧州
  • 英国
  • ドイツ
  • イタリア
  • フランス
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • 中国
  • インド
  • 日本
  • ASEAN
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
  • 中東
  • GCC
  • イスラエル
  • その他中東
  • アフリカ
  • 北アフリカ
  • 中央アフリカ
  • 南アフリカ

第9章 競合情勢

  • Novartis International AG
  • Mylan NV
  • Teva Pharmaceutical Industries Ltd.
  • Amneal Pharmaceuticals, Inc.
  • Mallinckrodt Pharmaceuticals
  • Anqiu Lu'an Pharmaceutical Co., Ltd.
  • Granules India Limited
  • Zhejiang Kangle Pharmaceutical Co., Ltd.
  • Farmson Pharmaceutical Gujarat Pvt. Ltd.
  • Atabay Pharmaceutical Factory
  • Anhui Fubore Pharmaceutical & Chemical Co., Ltd.
  • Huzhou Konch Pharmaceutical Co., Ltd.
  • Alnylam Pharmaceuticals Inc.
  • Eton Pharmaceuticals, Inc.
  • Eisai Inc.

第10章 セクション

  • 調査手法
  • 出版社について
目次
Product Code: CMI4251

Global pediatric palliative care drugs market is estimated to be valued at US$ 83.1 billion in 2023 and is expected to exhibit a CAGR of 5.1% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 83.1 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 5.10% 2030 Value Projection: US$ 117.8 Bn
Pediatric Palliative Care Drugs Market - IMG1

Pediatric palliative care is specialized medical care for children living with a serious illness. Palliative care focuses on providing relief from the symptoms and stress of the illness. The goal is to improve quality of life for both the child and the family. Pediatric palliative care is appropriate at any age and any stage of illness. It is appropriate for neonates, perinates, infants, children, adolescents, and young adults, and it can be provided along with treatment. Pediatric palliative care addresses serious medical conditions including genetic disorders, cancer, prematurity, neurologic disorders, heart and lung conditions, and others. It relieves the symptoms of these diseases such as pain, shortness of breath, fatigue, constipation, nausea, loss of appetite and difficulty sleeping, anxiety and depression. In short, it helps the child and the family improve their quality of life. Pediatric palliative care is an interdisciplinary collaboration that seeks to improve the quality of life for children with life-threatening conditions, as well as their families. The World Health Organization (WHO) defines pediatric palliative care as the active total care of the child's body, mind and spirit, which also involves giving support to the family. Different drugs most commonly used in palliative care are paracetamol, ibuprofen, morphine, bisacodyl, metronidazole, domperidone, dexamethasone, and diazepam. It is also used to treat serious disorders like chronic diseases such as kidney failure, Amyotrophic Lateral Sclerosis (ALS), cancer, Parkinson's disease, Chronic Obstructive Pulmonary Disease (COPD), and Congestive Heart Failure (CHF).

Market Dynamics

Increasing new product launches, and mergers and acquisitions by key market players are expected to drive the global pediatric palliative care drugs market growth. For instance, on April 1, 2022, Eisai Co., Ltd., a Japan-based pharmaceutical company announced the acquisition of Arteryex Inc., a Japan-based healthcare blockchain startup, to strengthen and rapidly expand the foundation of its digital solution business. The two companies will work together to develop and provide Personal Health Record (PHR)-related services for patients, healthcare professionals, and society at large.

Key features of the study:

  • This report provides an in-depth analysis of the global pediatric palliative care drugs market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global pediatric palliative care drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of this study include Novartis International AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Anqiu Lu'an Pharmaceutical Co., Ltd., Granules India Limited, Zhejiang Kangle Pharmaceutical Co., Ltd., Farmson Pharmaceutical Gujarat Pvt. Ltd., Atabay Pharmaceutical Factory, Anhui Fubore Pharmaceutical & Chemical Co.,Ltd, Huzhou Konch Pharmaceutical Co., Ltd., Alnylam Pharmaceuticals Inc., Eton Pharmaceuticals, Inc, and Eisai Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global pediatric palliative care drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pediatric palliative care drugs market

Detailed Segmentation:

  • Global Pediatric Palliative Care Drugs Market, By Drug Class:
    • Analgesics
    • Anti-emetics
    • Laxatives
    • Adjuvant Medications
    • Steroids
    • Sedatives
    • Neuroleptic Medications
    • Others
  • Global Pediatric Palliative Care Drugs Market, By Route of Administration:
    • Oral
    • Topical
    • Parenteral
  • Global Pediatric Palliative Care Drugs Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Pediatric Palliative Care Drugs Market, By Region:
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Novartis International AG
    • Mylan NV
    • Teva Pharmaceutical Industries Ltd.
    • Amneal Pharmaceuticals, Inc.
    • Mallinckrodt Pharmaceuticals
    • Anqiu Lu'an Pharmaceutical Co., Ltd.
    • Granules India Limited
    • Zhejiang Kangle Pharmaceutical Co., Ltd.
    • Farmson Pharmaceutical Gujarat Pvt. Ltd.
    • Atabay Pharmaceutical Factory
    • Anhui Fubore Pharmaceutical & Chemical Co., Ltd
    • Huzhou Konch Pharmaceutical Co., Ltd.
    • Alnylam Pharmaceuticals Inc.
    • Eton Pharmaceuticals, Inc
    • Eisai Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Drug Class
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Pediatric Palliative Care Drugs Market - COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Pediatric Palliative Care Drugs Market, By Drug Class, 2018-2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Analgesics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Anti-emetics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Laxatives
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Adjuvant Medications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Steroids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Sedatives
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Neuroleptic Medications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

6. Global Pediatric Palliative Care Drugs Market, By Route of Administration, 2018-2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Parenteral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

7. Global Pediatric Palliative Care Drugs Market, By Distribution Channel, 2018-2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

8. Global Pediatric Palliative Care Drugs Market , By Region, 2018-2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2018-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030, (US$ Billion)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Novartis International AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Mylan NV
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Teva Pharmaceutical Industries Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Amneal Pharmaceuticals, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Mallinckrodt Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Anqiu Lu'an Pharmaceutical Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Granules India Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Zhejiang Kangle Pharmaceutical Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Farmson Pharmaceutical Gujarat Pvt. Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Atabay Pharmaceutical Factory
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Anhui Fubore Pharmaceutical & Chemical Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Huzhou Konch Pharmaceutical Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Alnylam Pharmaceuticals Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Eton Pharmaceuticals, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Eisai Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

10. Section

  • Research Methodology
  • About Us